Search for: "PFIZER INCĀ " Results 1141 - 1160 of 1,505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jan 2015, 4:00 am by Kimberly A. Kralowec
Pfizer, Inc. (2010) 49 Cal.4th 758 in which the Supreme Court held retail pharmacies had standing to assert UCL claims against pharmaceutical companies that had allegedly engaged in price fixing even though the retail pharmacies were able to pass on any overcharges to their customers. [read post]
6 Nov 2015, 6:58 am
 The patent belongs Warner-Lambert, a company that was acquired by Pfizer in 2000. [read post]
23 Oct 2008, 10:31 am
"        According to the AP (10/22, Tanner), other "drugs under examination are Genentech Inc.'s psoriasis drug Raptiva (efalizumab), which just last week the Food and Drug Administration (FDA) warned may contribute to a life-threatening brain illness and infections; and Exubera, an inhaled insulin product, linked with lung cancer risks," which "Pfizer Inc. stopped selling...last year. [read post]
27 Jul 2012, 12:40 pm by Bexis
Pfizer, Inc., 990 A.2d 17, 21 n.1 (Pa.Super. 2010) (rejecting fraud claim concerning promotion “for off-label uses for which the effectiveness had not been scientifically demonstrated”). [read post]
2 Jun 2011, 12:46 pm by Bexis
Pfizer, Inc., 153 S.W.3d 758, 761 (Ky. 2004) (dictum also extends rule to medical devices). [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog)   General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court… [read post]
2 Jun 2011, 11:00 am by Erica Siepman
Gray currently serves as a director for Prudential Financial, Inc., Dell Computer Corporation, and Pfizer Inc. [read post]
22 Jul 2009, 6:00 am
" Drugmakers including New York-based Pfizer Inc. may benefit from an aging population, said Thomas Lee, chief U.S. equity strategist at JPMorgan Chase & Co. in New York. [read post]